Search
for
Sort by
Research 451–480 of 1000+
- Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units
- Microneedling dilates the follicular infundibulum and increases transfollicular absorption of liposomal sepia melanin
- Safety and efficacy analysis of liposomal insulin-like growth factor-1 in a fluid gel formulation for hair-loss treatment in a hamster model
- A multifunctional cholesterol-free liposomal platform based on protopanaxadiol for alopecia therapy
- Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia
- Role of liposomal drug-delivery system in cosmetics
- Development and Characterization of Dutasteride Bearing Liposomal Systems for Topical Use
- Acceleration of Hair Growth Rate by Topical Liposomal Cepharanthine in Male Androgenetic Alopecia
- Liposomal Helix aspersa Snail Mucus: A Biomacromolecular Platform for Attenuating Chronological Skin Aging Through Modulation of miR-34a-Associated Senescence and Extracellular Matrix Remodeling
- Targeted Follicular Delivery via Liposomal Encapsulation of Sesbania grandiflora - Enhances Hair and Scalp Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Targeted Follicular Delivery via Liposomal Encapsulation of Sesbania grandiflora - Enhances Hair and Scalp Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
- QbD based Formulation for Liposomal Combination of AdapaleneClindamycin with Gel Matrix for Enhanced Acne Treatment
- Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects
- Formulation and Evaluation of Liposomal Herbal Hair Serum Using Alkanet Root Extract
- A Review on an Evaluation of a Liposomal Hydrogel for Combined Minoxidil and Tretinoin Delivery in Androgenetic Alopecia
- Cardamonin-loaded liposomal formulation for improving percutaneous penetration and follicular delivery for androgenetic alopecia
- Liposomal Bupivacaine
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Endosymbiosis-inspired engineering of mitochondrial-enriched extracellular vesicles supercharges host mitochondria via the autophagy-lysosome pathway
- Inhibition of autophagy-lysosomal function exacerbates microglial and monocyte lipid metabolism reprograming and dysfunction after brain injury
- Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin
- Role of liposomal anthracyclines in the treatment of multiple myeloma
- Effect of liposomal fluidity on skin permeation of sodium fluorescein entrapped in liposomes
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma
- Skin permeation of different steroid hormones from polymeric coated liposomal formulations
- Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
- Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients